Key benefits include: Like all medications, semaglutide may cause some side effects, especially when first starting treatment
Weeks 5 to 8: Dose Adjustment Phase Increased Dose: After 4 weeks, the dose may be increased to 0.5 mg weekly
Injectable semaglutide improves blood sugar control for people with diabetes
P = Type 2 diabetes patients with high cardiovascular risk
The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns
, ,